Collegium Pharmaceutical, Inc. (COLL)
22.02
+0.18
(+0.82%)
USD |
NASDAQ |
Oct 02, 16:00
22.05
+0.03
(+0.14%)
After-Hours: 20:00
Collegium Pharmaceutical Price to Book Value : 2.294 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.294 |
| October 01, 2026 | 2.276 |
| September 30, 2026 | 2.274 |
| September 29, 2026 | 2.316 |
| September 28, 2026 | 2.358 |
| September 25, 2026 | 2.347 |
| September 24, 2026 | 2.359 |
| September 23, 2026 | 2.339 |
| September 22, 2026 | 2.374 |
| September 21, 2026 | 2.401 |
| September 18, 2026 | 2.372 |
| September 17, 2026 | 2.332 |
| September 16, 2026 | 2.312 |
| September 15, 2026 | 2.276 |
| September 14, 2026 | 2.377 |
| September 11, 2026 | 2.370 |
| September 10, 2026 | 2.388 |
| September 09, 2026 | 2.434 |
| September 08, 2026 | 2.435 |
| September 04, 2026 | 2.452 |
| September 03, 2026 | 2.469 |
| September 02, 2026 | 2.532 |
| September 01, 2026 | 2.501 |
| August 31, 2026 | 2.564 |
| August 28, 2026 | 2.641 |
| Date | Value |
|---|---|
| August 27, 2026 | 2.755 |
| August 26, 2026 | 2.866 |
| August 25, 2026 | 2.862 |
| August 24, 2026 | 2.850 |
| August 21, 2026 | 2.825 |
| August 20, 2026 | 2.869 |
| August 19, 2026 | 2.994 |
| August 18, 2026 | 2.970 |
| August 17, 2026 | 2.925 |
| August 14, 2026 | 2.941 |
| August 13, 2026 | 2.933 |
| August 12, 2026 | 2.678 |
| August 11, 2026 | 2.707 |
| August 10, 2026 | 2.834 |
| August 07, 2026 | 3.070 |
| August 06, 2026 | 3.033 |
| August 05, 2026 | 3.724 |
| August 04, 2026 | 3.723 |
| August 03, 2026 | 3.707 |
| July 31, 2026 | 3.687 |
| July 30, 2026 | 3.749 |
| July 29, 2026 | 3.781 |
| July 28, 2026 | 3.740 |
| July 27, 2026 | 3.701 |
| July 24, 2026 | 3.668 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Innoviva, Inc. | 1.207 |
| Zevra Therapeutics, Inc. | 2.724 |
| ANI Pharmaceuticals, Inc. | 2.776 |
| Corcept Therapeutics, Inc. | 17.77 |
| Veru, Inc. | 1.508 |
Price to Book Value Related Metrics
| PE Ratio | 17.84 |
| PS Ratio | 1.036 |
| PEG Ratio | 0.9315 |
| Price to Free Cash Flow | 2.550 |
| Price | 22.02 |
| Earnings Yield | 5.61% |
| Market Cap | 715.61M |
| PEGY Ratio | 0.9315 |
| Operating PE Ratio | 5.148 |
| Normalized PE Ratio | 13.65 |